Jubilant Prodel LLC has a total of 16 patent applications. Its first patent ever was published in 2018. It filed its patents most often in Australia, Brazil and Canada. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are JUBILANT BIOSYS LTD, GEA AS and HOLDING CERESIA S A.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 2 | |
#2 | Brazil | 2 | |
#3 | Canada | 2 | |
#4 | EPO (European Patent Office) | 2 | |
#5 | Israel | 2 | |
#6 | Republic of Korea | 2 | |
#7 | Singapore | 2 | |
#8 | China | 1 | |
#9 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Acyclic or carbocyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Rajagopal Sridharan | 12 |
#2 | Venkateshappa Chandregowda | 12 |
#3 | Duraiswamy Athisayamani Jeyaraj | 6 |
#4 | Sivanandhan Dhanalakshmi | 6 |
#5 | Pendyala Muralidhar | 6 |
#6 | Putta Rama Kishore V P | 6 |
#7 | D A Jeyaraj | 5 |
#8 | Sridharan Rajagopal | 2 |
#9 | Chandregowda Venkateshappa | 2 |
#10 | Da Jeyaraj | 1 |
Publication | Filing date | Title |
---|---|---|
AU2019234185A1 | Bicyclic compounds as inhibitors of PD1/PD-L1 interaction/activation | |
BR112020008851A2 | compound of formula i, process for preparing compounds of formula i, pharmaceutical composition, method for treating and / or preventing various diseases, use, method for treating cancer, method of treating cancer and method for treating and / or prevention of cancer and infectious diseases |